Freshfields‘s shareholder litigation team offers considerable trial experience to clients facing suits linked to both M&A activities and corporate governance issues, including allegations of breaches of fiduciary duties by company directors and officers. In New York, Meredith Kotler and Mary Eaton specialize in defending stockholder challenges to M&A deals and tackling securities class actions; recently they secured the dismissal of several claims brought by Viela stockholders against AstraZeneca, alleging that its 2018 spinoff of Viela was done at below market value and under pressure from AstraZeneca officers. Kotler and Eaton spearhead the firm’s M&A litigation alongside Silicon Valley-based Boris Feldman, who represents an impressive roster of tech clients in securities and M&A disputes, notably advising Tesla in response to shareholder claims that the board failed to act in relation to a number of business indiscretions committed by CEO Elon Musk.
Legal 500 Editorial commentary

Lawyers

Hall of Fame

The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

Meredith Kotler; Mary Eaton;

Other key lawyers

Doru Gavril; Nicholas Caselli; Boris Feldman

L500 | Freshfields > M&A litigation: defense > United States | Legal 500 law firm profiles